Congress marked up healthcare bills, held a China research security hearing, and debated federal AI preemption today. Markets were too busy watching earnings to notice.

PPI surprised to the downside. ASML raised its outlook for the third time this year. Warsh told Congress one data point is not enough. And while everyone watched earnings, three of the most consequential policy hearings of the year happened simultaneously on Capitol Hill.

Earnings season has a gravitational pull. Everything orbits around it. That is exactly when the policy moves that actually reshape industries happen quietly in committee rooms. Today was one of those days.


Three committee hearings happened today that will matter more than the PPI number in six months.

While markets were digesting PPI data and ASML earnings this morning, three separate congressional hearings were running simultaneously on Capitol Hill that deserve more attention than they got.

The House Ways and Means Committee marked up a bipartisan healthcare package today covering Medicare beneficiaries, rural providers, and privately insured patients. The package includes prior authorization reform, expanded remote patient monitoring in rural communities, enhanced ACA premium tax credit extensions, and essential caregiver access legislation. Prior authorization reform alone, which requires insurers to respond faster to coverage requests, is a structural change to how healthcare reimbursement flows between insurers and providers. That affects every hospital system, every rural clinic, and every health insurer's cost structure simultaneously. It is not a headline story. It is a revenue model story.

Separately, the House Select Committee on Strategic Competition between the US and the Chinese Communist Party held a hearing titled "Protecting American Innovation: The Federal Research Security Enterprise," with witnesses from the National Science Foundation, Department of Energy, and NIH. This hearing is the legislative follow-through to the pharma national security investigation we covered on June 30, when Congress sent letters to Merck, AbbVie, Lilly, Pfizer, and Bristol Myers Squibb about their clinical trial operations at Chinese military hospitals. The research security hearing is Congress building the institutional architecture to do systematically what it did to those five pharma companies individually. That architecture, once built, changes the compliance calculus for every research institution and company with Chinese academic or laboratory partnerships.

And the Senate HELP Committee held a confirmation hearing today for the next CDC director and the next Assistant Secretary for Preparedness and Response, two positions that have been vacant through a year that included New World screwworm, hantavirus, and a resurgence of Ebola. The people confirmed into those roles in the next few weeks will be responsible for the next public health emergency response. That is not a markets story today. It is a markets story the day something goes wrong.


The Great American AI Act just proposed three years of federal preemption of state AI laws. States have 14 laws on the books.

A 269-page bipartisan discussion draft of the Great American Artificial Intelligence Act, introduced by Reps. Jay Obernolte and Lori Trahan, proposes a three-year preemption of state laws specifically regulating the development of any AI model. The bill would require frontier AI developers to disclose model information and obtain third-party audits through designated Independent Verification Organizations, and would create a federal framework for AI governance that supersedes the patchwork of state laws currently in effect.

The Capital to Capitol read connects directly to the thread we have been tracking since June 30 when Colorado's SB 24-205 took effect. We noted then that multi-state healthcare operators were already building compliance programs to the strictest rule on the books because guessing wrong on federal preemption was the expensive outcome. The GAAIA's three-year preemption proposal answers that question with a specific timeline — if this passes, the compliance infrastructure every company has been building toward Colorado's standard becomes either the federal floor or an expensive redundancy, depending on how the preemption is written. Three years of federal preemption over a 14-law state landscape is not a regulatory simplification. It is a regulatory reset, and the companies positioned ahead of it are the ones that built compliance programs assuming the federal floor would eventually arrive. The ones that waited are now racing a different clock.

Separately, Google DeepMind CEO Demis Hassabis called yesterday for the US to establish a new AI watchdog with the power to screen the world's most advanced models and coordinate an industry-wide slowdown if dangers mount. That proposal, from the CEO of one of the most advanced AI labs on earth, lands the day after OpenAI proposed giving the government equity in exchange for regulatory goodwill. Two of the most powerful actors in AI are both trying to shape their regulatory environment in the same week. The difference is revealing: OpenAI wants the government as a financial stakeholder. DeepMind wants the government as a safety cop. Those are not the same bet on how AI regulation ends.


PPI and ASML: the inflation and semiconductor reads in brief.

The Producer Price Index unexpectedly fell 0.3% in June against expectations of unchanged, while the annual rate came in at 5.5%. ASML raised its full-year 2026 financial forecasts for the third time this year, citing accelerating AI-driven demand for advanced logic and memory chips. Shares rose 3.6%.

The honest read on both: PPI is capturing June, the same month as CPI, the same ceasefire window, the same temporary energy relief. The relief is real and the numbers are good. They are also already out of date. ASML's third upward revision is the more durable signal — it reflects order book data from every major chipmaker on earth, not a one-month energy price move. When ASML raises its outlook three times in a single year, the AI capital cycle has not peaked. That is the number worth carrying into next week.


The continuity thread: Warsh said something today that landed quietly.

Warsh testified before the Senate Banking Committee today, his second consecutive day of congressional testimony. He told lawmakers that one data point was not enough to declare victory over inflation. The probability of a rate hold at the July 29 meeting is now at 84.5% according to CME FedWatch.

The quiet detail: Warsh said it the morning after two consecutive softer-than-expected inflation prints, during an active Hormuz blockade, with the IRGC threatening today to close all other export corridors that benefit the US. He is not celebrating. He is holding the line against a market that is pricing relief from a data set that describes a world two weeks ago. That restraint is itself a signal. A chair who withheld his dot plot, called his committee a family fight, and committed to less communication than his predecessors does not say "one data point is not enough" casually. He says it because he means it, and because the August 12 CPI print will say something very different than today's PPI did.


The thread underneath Wednesday

Three committee hearings reshaping healthcare, national security research, and AI regulation happened today while markets watched earnings. The GAAIA proposed three years of federal preemption over 14 state AI laws. DeepMind and OpenAI both tried to shape their regulatory futures in opposite directions in the same week. ASML confirmed the AI cycle has not peaked. Warsh confirmed the Fed has not declared victory. And the IRGC threatened to extend the conflict beyond Hormuz while the PPI surprised to the downside.

Today was not a markets day wearing a policy costume. It was a policy day that markets chose not to look at. That gap — between what moved prices and what will matter in six months — is where Capital to Capitol lives.

What to watch tomorrow: Taiwan Semiconductor reports before the open. TSMC manufactures the chips ASML's machines produce and its order book is the ground truth of AI demand. UnitedHealth also reports, the first major read on healthcare costs in a post-Colorado-AI-law environment. And retail sales for June drops at 8:30 AM — the first hard look at whether the American consumer held through the Iran war's peak energy cost impact.


Capital to Capitol publishes every evening, five days a week. Subscribe free below and today's brief lands in your inbox by 9 PM.